We are live on ! Find out more
TMDX icon

Transmedics

432 hedge funds and large institutions have $4.53B invested in Transmedics in 2025 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 155 increasing their positions, 129 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 45

68% more call options, than puts

Call options by funds: $98.1M | Put options by funds: $58.2M

26% more capital inflows, than outflows

Capital inflows: $435M | Capital outflows: $344M

20% more repeat investments, than reductions

Existing positions increased: 155 | Existing positions reduced: 129

10% more funds holding

Funds holding: 391 → 432 (+41)

0.21% less ownership

Funds ownership: 109.07% → 108.86% (-0.21%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
432
Holders Change
+41
Holders Change %
+10.49%
% of All Funds
5.19%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
89
Increased
155
Reduced
129
Closed
45
Calls
$98.1​M
Puts
$58.2​M
Net Calls
+$39.8​M
Net Calls Change
+$25.2​M

TMDX Hedge Fund Activity: Q4 2025 in Review

432 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q4 2025, worth a combined $4.53B — up 8.5% from $4.17B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new TMDX positions and 45 closed out — a net gain of 44 holders — while 155 added to existing stakes and 129 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $32.9M. The largest seller was Marshall Wace, cutting an estimated $44.1M.

  • 432 institutional investors held Transmedics (TMDX) as of Q4 2025, up from 391 in Q3 2025.
  • Funds reported $4.53B of Transmedics stock for Q4 2025, up 8.5% quarter-over-quarter.
  • 89 funds opened new Transmedics positions in Q4 2025 and 45 closed out, a net change of +44 holders.
  • The largest Transmedics buyer in Q4 2025 was Goldman Sachs, an estimated $32.9M added.
  • The largest Transmedics seller in Q4 2025 was Marshall Wace, an estimated $44.1M sold.

Based on aggregated 13F filings for Q4 2025.